The EPS projection of Genpact Limited (NYSE:G) for quarter ended 2016-09-30 is $0.34. A week before, the EPS forecast was $0.34 against target of $0.34, a month earlier. This estimate stood at $0.34 60 days earlier versus forecast of $0.34 90 days earlier, confirming a deviation of 0%.
Genpact Limited (NYSE:G) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 2, 1, 0 and 1, respectively.
The downgrade of EPS estimates for Genpact Limited (NYSE:G) in the preceding 120, 60, 30 and 90 days were 2, 2, 0 and 2, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Genpact Limited (NYSE:G) was $0.34. This projection was computed after accounting 4 calls. As reported on 2016-05-05 the EPS was $0.29. The change was $0.01, demonstrating a percentage deviation of 3.57%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Genpact Limited (NYSE:G) stands at $769.42 and the median estimate at $766. Almost 3 analysts announced their estimates.
The highest estimate is $783.74 while the lowest target is $758.52 showing standard deviation of 12.953%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. Genpact Limited (NYSE:G) stated that the change in forecast was -1.41%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...